the ability of nafoxidine to bind in vitro to cytoplasmic or nuclear estrogen receptors was , respectively , 4 % and 2 % ( hpoa ) , 5 % and 6 % ( pituitary ) , and 1 % and 2 % ( uterus ) relative to e2 ( 100 % ) .
C0010834
cytoplasmic
C0206588
nuclear